Director Johnny Powers buys 200K Zomedica (ZOMDF) shares

Rhea-AI Filing Summary

Zomedica Corp. director Johnny D. Powers reported buying a total of 200,000 shares of common stock in open-market purchases at $0.103 per share. After these non-derivative transactions, he directly holds 4,325,000 shares of Zomedica common stock, increasing his personal equity stake in the company.

Insider Trade Summary

Net Buyer: 200,000 shares ($20,600)

Net Buy 3 txns

Insider POWERS JOHNNY D

Role null

Bought 200,000 shs ($21K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, without par value	100,000	$0.103	$10K
Purchase	Common stock, without par value	2,485	$0.103	$255.95
Purchase	Common Stock, without par value	97,515	$0.103	$10K

Holdings After Transaction: Common Stock, without par value — 4,325,000 shares (Direct, null); Common stock, without par value — 4,327,485 shares (Direct, null)

Footnotes (1)

Key Figures

Shares bought: 200,000 shares Purchase price: $0.103 per share Shares after transaction: 4,325,000 shares +2 more

5 metrics

Shares bought 200,000 shares Total open-market purchases reported

Purchase price $0.103 per share Price for each reported transaction

Shares after transaction 4,325,000 shares Direct holdings following transactions

Number of buy transactions 3 purchases Non-derivative open-market trades

Net buy direction net-buy of 200,000 shares Transaction summary

Key Terms

open-market purchase, non-derivative, Common Stock, without par value, total_shares_following_transaction

4 terms

open-market purchase financial

"transaction_action": "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

non-derivative financial

""transaction_type": "non-derivative""

Common Stock, without par value financial

""security_title": "Common Stock, without par value""

total_shares_following_transaction financial

""total_shares_following_transaction": "4325000.0000""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POWERS JOHNNY D

(Last) (First) (Middle)

1101 TECHNOLOGY DRIVE

STE 100

(Street)

ANN ARBOR. MICHIGAN 48108

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Zomedica Corp. [ ZOMDF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, without par value	05/18/2026		P		100,000	A	$0.103	4,325,000	D
Common stock, without par value	05/19/2026		P		2,485	A	$0.103	4,327,485	D
Common Stock, without par value	05/20/2026		P		97,515	A	$0.103	4,425,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/Johnny D. Powers	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider activity did Zomedica (ZOMDF) report in this Form 4?

Zomedica reported that director Johnny D. Powers made open-market purchases of common stock. He bought a total of 200,000 shares at $0.103 per share, increasing his direct ownership to 4,325,000 shares of Zomedica common stock.

How many Zomedica (ZOMDF) shares did Johnny D. Powers buy?

Johnny D. Powers bought 200,000 Zomedica common shares in total. The Form 4 shows three separate open-market purchase transactions, which together add up to this 200,000-share increase in his directly held position in the company.

What price did Johnny D. Powers pay for Zomedica (ZOMDF) shares?

All reported purchases were made at a price of $0.103 per Zomedica common share. Each of the three non-derivative transactions in the Form 4 lists this same per-share purchase price for the open-market acquisitions.

What is Johnny D. Powers’ total Zomedica (ZOMDF) shareholding after these trades?

Following the reported transactions, Johnny D. Powers directly owns 4,325,000 Zomedica common shares. This post-transaction figure reflects his updated stake after adding the 200,000 shares acquired through the open-market purchases disclosed in the Form 4.

Were the Zomedica (ZOMDF) transactions by Johnny D. Powers derivative or non-derivative?

The Form 4 shows all of Johnny D. Powers’ transactions as non-derivative. He purchased common stock directly in the open market, rather than exercising options or converting derivative securities, and there are no remaining derivative positions listed for him in this filing.

Is the Zomedica (ZOMDF) Form 4 transaction a buy or a sell?

The Form 4 reflects only buy transactions by Johnny D. Powers. Each entry is coded as an open-market purchase, and the transaction summary shows 200,000 net shares bought, with no sales or other dispositions reported in this filing.